FDA puts Bristol-Myers' Opdivo-Yervoy combo in fast lane for new kidney cancer nod

14th December 2017 Uncategorised 0

Bristol-Myers Squibb could have yet another approval for its Opdivo-plus-Yervoy combo on the way. The FDA has started a priority review on the two-drug combo as a treatment for kidney cancer, based on data released just three months ago.

More: FDA puts Bristol-Myers' Opdivo-Yervoy combo in fast lane for new kidney cancer nod
Source: fierce